Anika Therapeutics, Inc. is a company dedicated to joint preservation, innovating and providing early intervention orthopedic care across the globe, including the United States and Europe. Their core focus areas include osteoarthritis (OA) pain management, regenerative solutions, soft tissue repair, and advanced bone-preserving joint technologies. All of Anika's products are developed, manufactured, and commercialized utilizing their proprietary hyaluronic acid (HA) technology platform. Their comprehensive product lines feature an OA pain management family, which includes established…
| Price | $20.61 |
|---|---|
| Market cap | $275.82M |
| Sector | Healthcare |
| Industry | Medical - Specialties |
| Exchange | NASDAQ |
| 52-week range | 8.67-22.88 |
| Beta | 0.2 |
Explore ANIK's full valuation scorecard, price history, financial statements, insider and institutional ownership, and peer comparison on this page — free, no login required.